- Insolvency Insider Canada
- Posts
- Avivagen Inc. (TSXV:VIV), Bankruptcy
Avivagen Inc. (TSXV:VIV), Bankruptcy
![](https://media.beehiiv.com/cdn-cgi/image/fit=scale-down,format=auto,onerror=redirect,quality=80/uploads/asset/file/e20a27a4-a8b6-4981-868f-6e7ee630732a/christopher-carson-i4XLJmlYit4-unsplash.jpg?t=1715625525)
Avivagen Inc. (TSXV:VIV), an Ottawa, Ontario-based life sciences company which specialized in natural immune-boosting substances for pigs and cattle, filed an assignment in bankruptcy on April 23 listing $10.4 million in liabilities, including $6.1 million to Capital Transfer Agency and $2.9 million to Atlantic Canada Opportunities Agency.
Prior to the filing, the company conducted a strategic review process which culminated in a potential purchaser submitting a non-binding LOI. However, the deal failed to materialize and the company made the decision to file for bankruptcy.
BDO is the bankruptcy trustee.
By: Dina Milivojevic